Algorithmiq focuses on revolutionizing life sciences through the potential of quantum computing in the life sciences and technology sectors. The company specializes in developing algorithms that address complex problems in life sciences, particularly for molecular structure prediction, drug discovery and drug design, using quantum computing. Algorithmiq's solutions aim to enhance the capabilities of near-term quantum computers to tackle challenges in the life sciences field. It was founded in 2020 and is based in Helsinki, Finland.